These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 440322)

  • 1. Procarbazine-induced specific-locus mutations in male mice.
    Ehling UH; Neuhäuser A
    Mutat Res; 1979 Feb; 59(2):245-56. PubMed ID: 440322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of specific-locus mutations in female mice by 1-ethyl-1-nitrosourea and procarbazine.
    Ehling UH; Neuhäuser-Klaus A
    Mutat Res; 1988 Nov; 202(1):139-46. PubMed ID: 3185586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse spermatogonia exposed to a high, multiply fractionated dose of a cancer chemotherapeutic drug: mutation analysis by electrophoresis.
    Johnson FM; Lewis SE
    Mutat Res; 1981 Apr; 81(2):197-202. PubMed ID: 7242541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant lethal mutations induced in mouse spermatogonia by mechlorethamine, procarbazine and vincristine administered in 2-drug and 3-drug combinations.
    Goldstein LS
    Mutat Res; 1987; 191(3-4):171-6. PubMed ID: 3627154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of dominant cataract and recessive specific-locus mutations in mice derived from 80 or 160 mg ethylnitrosourea per kg body weight treated spermatogonia.
    Favor J
    Mutat Res; 1986 Aug; 162(1):69-80. PubMed ID: 3724777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant cataract and recessive specific-locus mutations detected in offspring of procarbazine-treated male mice.
    Kratochvilova J; Favor J; Neuhäuser-Klaus A
    Mutat Res; 1988 Apr; 198(2):295-301. PubMed ID: 3352637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleomycin, unlike other male-mouse mutagens, is most effective in spermatogonia, inducing primarily deletions.
    Russell LB; Hunsicker PR; Kerley MK; Johnson DK; Shelby MD
    Mutat Res; 2000 Aug; 469(1):95-105. PubMed ID: 10946246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mouse specific-locus test with agents other than radiations: interpretation of data and recommendations for future work.
    Russell LB; Selby PB; von Halle E; Sheridan W; Valcovic L
    Mutat Res; 1981 May; 86(3):329-54. PubMed ID: 7029264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and nature of specific-locus mutations induced in female mice by radiations and chemicals: a review.
    Russell LB; Russell WL
    Mutat Res; 1992 Dec; 296(1-2):107-27. PubMed ID: 1279398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-repetition increases the mutagenic effectiveness of N-ethyl-N-nitrosourea in mouse spermatogonia.
    Hitotsumachi S; Carpenter DA; Russell WL
    Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6619-21. PubMed ID: 3863118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of sister-chromatid exchanges by chemotherapeutic drugs in spermatogonia of mice: effects of procarbazine, adriamycin, cyclophosphamide and mitomycin C.
    Abraham SK; Fränz J
    Mutat Res; 1983 Mar; 108(1-3):373-81. PubMed ID: 6835229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant lethal mutations induced in mouse spermatogonia by antineoplastic drugs.
    Goldstein LS
    Mutat Res; 1984 Aug; 140(4):193-7. PubMed ID: 6472329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzo(a)pyrene Is Mutagenic in Mouse Spermatogonial Stem Cells and Dividing Spermatogonia.
    O'Brien JM; Beal MA; Yauk CL; Marchetti F
    Toxicol Sci; 2016 Aug; 152(2):363-71. PubMed ID: 27208087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of specific locus mutations in mouse spermatogonial stem cells by combined chemical X-ray treatments.
    Cattanach BM; Peters J; Rasberry C
    Mutat Res; 1989 May; 212(1):91-101. PubMed ID: 2725545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dose fractionation on the ethylnitrosourea induction of specific-locus mutations in mouse spermatogonia.
    Russell WL; Hunsicker PR; Carpenter DA; Cornett CV; Guinn GM
    Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3592-3. PubMed ID: 6954506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic potency and specificity of procarbazine in the ad-3 forward-mutation test in growing cultures of heterokaryon 12 of Neurospora crassa.
    Brockman HE; de Serres FJ
    Mutat Res; 1991 Jan; 246(1):193-204. PubMed ID: 1824718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotoxic potency in mouse spermatogonial stem cells of triethylenemelamine, mitomycin C, ethylnitrosourea, procarbazine, and propyl methanesulfonate as measured by F1 congenital defects.
    Nagao T; Fujikawa K
    Mutat Res; 1990 Apr; 229(2):123-8. PubMed ID: 2157148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of dominant cataract and recessive specific-locus mutations and mutation mosaics in F1 mice derived from post-spermatogonial treatment with ethylnitrosourea.
    Favor J; Neuhäuser-Klaus A; Ehling UH
    Mutat Res; 1990 Apr; 229(2):105-14. PubMed ID: 2320023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dose dependencies of mutations of germ cells in mice].
    Eling UKh
    Tsitol Genet; 1986; 20(3):180-90. PubMed ID: 3750408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-response analysis of ethylnitrosourea-induced recessive specific-locus mutations in treated spermatogonia of the mouse.
    Favor J; Sund M; Neuhäuser-Klaus A; Ehling UH
    Mutat Res; 1990 Jul; 231(1):47-54. PubMed ID: 2366775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.